Your Daily News Roundup
Everything you need to know this week about type 1 diabetes and coronavirus updates, in one easy-to-read place!
Researchers, advocates, clinicians, and organizations around the country and across the web have been hard at work, creating resources for people living with T1D to better handle the ongoing COVID-19 coronavirus pandemic.
We’re taking the opportunity each week to share some of those resources that may help people get through this challenging time with the help of partners and experts.
We will be sharing the most recent, most relevant content from Beyond Type 1, JDRF, and more!
Take a look!
Here are some of the stories to keep an eye on this week.
- Qutenza, a newly approved non-opioid patch for diabetic neuropathy, has been shown to help relieve pain caused by nerve damage from diabetes. Read more here.
- COVID-19: Managing Your Weight During a Pandemic. Staying at home due to COVID-19 has been a challenge for all of us, and weight gain is an unforeseen consequence that many people are now dealing with. Get tips to manage those numbers on the scale.
- Detecting Type 1 Diabetes in Children. Share the symptoms of T1D, now more than ever. COVID-19 is causing people to delay trips to the doctor, which makes awareness even more essential. Learn all about how to detect type 1 diabetes in children and youth: signs, symptoms, and treatments.
- An Insulin Pump Guide from DiabetesMine. Looking for the best insulin pump? Learn about currents models and new diabetes technology on the horizon.
- Routine screening for food insecurity by healthcare professionals is extremely important. Check out this piece about Food Insecurity and Diabetes, A Dangerous Combination.
- The “Legacy Effect” in Diabetes – The Long-Term Benefits of Short-Term, Tight Glucose Management. A summary of landmark trials shows that careful blood glucose management can lower the risk of long-term health complications in people with diabetes.
- Farxiga Shows Potential to Protect Millions of People with Chronic Kidney Disease. The SGLT-2 inhibitor Farxiga shows impressive results from its latest clinical trial: it slows the loss of kidney function and the risk of death in people with chronic kidney disease.
- diaTribe. Not Everyone Can Work From Home: Addressing Worker Safety During COVID-19. Staying home during COVID-19 is a privilege, and is not an option for many people, including those with T1D. As restrictions shift and people return to work, experts recommend ‘making work as safe as possible’. But what does that really mean? Find out here.
- We know it can be hard but it’s important to make sure you’re getting enough regular exercise, especially if you’re working from home. Maintain a healthy lifestyle while taking precautions during COVID-19. Visit http://coronavirusdiabetes.org for the list of precautions.
- Diabetes Training Camp has a new virtual camp offering this summer for those who are looking to do a deep dive on diabetes management for exercise and sports. Learn more here.
- Got questions on carb counting and dosing? Join in conversations on http://TuDiabetes.org to discover peer support on important T1D topics.
- Type 1 Pregnancy Risks and How to Minimize Them. Living with T1D does not mean you can not get pregnant; it just means that you have to be more vigilant and more prepared during the whole process. If you’re thinking about what a Type 1 pregnancy could look like for you, explore more here.
- August is Back To School Month. What will back to school look like for you and your family this year amidst COVID-19? Explore this article on the re-opening of schools and whether COVID-19 is harmful to children.
- Amidst COVID-19, JDRF has announced an updated strategy, prioritizing work in their portfolio that they see as having the highest likelihood for cures and life-changing advances for diabetes. What does this mean for research? Read up on the changes.
Here are a few of the most exciting and important resources that we’ve seen about this topic in the last few weeks — we’ll be updating the list regularly as time goes on!
- The Case for Flexible Work Schedules: For those who can work from home, some wonder if they want to ever return to office life. Read this piece from Christine Fallabel on how the change can be especially beneficial for people living with type 1 diabetes and other chronic conditions.
- Let’s celebrate the Americans with Disabilities Act (ADA) ???? ???????????! The ADA works to ensure all people with disabilities have the same rights and opportunities as everyone else. Learn more here.
- Join Friday at 3:00 p.m. ET, when @JDRF and @CollegeDiabetes Network will host a discussion on preparing and navigating the transition to college life, whether it be virtual, on campus, or a combination. Learn about accommodations, campus life, telling others about T1D, and get all your questions answered.
- diaTribe: As #HealthyVisionMonth comes to an end, check out these simple guidelines that will explain when you should be screened for retinopathy and what questions to ask your healthcare professional.
- What is chronic kidney disease? How is diabetes related to CKD? What can you do to support kidney health? Check out this article + download the CKD infographic to get answers to these questions and more.
- DiabetesMine: Another month in the books. Diabetes Mine shares favorite social media posts from around the Diabetes Online Community for July 2020.
Hesitant to participate in research? We get it, T1D Exchange takes data privacy and security seriously. We will do everything to ensure that the information you entrust us is secure.
- Study Links COVID-19 to Increased Rates of DKA at Diagnosis in Children. This week, a new study out of Germany (Click here for coverage in Spanish) showed increased rates of diabetic ketoacidosis (DKA) at diagnosis for people under the age of 18 amidst COVID-19. From March to May 2020, rates of DKA at diagnosis almost doubled compared to years prior, presenting in almost half of those diagnosed with Type 1 diabetes. This is most likely due to a delay in seeking medical care due to the complexities of life during COVID.
To address these trends and to prepare for the coming months when regular flu cases and Type 1 diabetes diagnoses tend to uptick, we are sharing this information about the Warning Signs of Type 1 Diabetes.
In the best of times, the warning signs can be hard to spot unless someone is aware. Download here posters and social media graphics. We invite you to spread the word about #T1DWarningSigns.
- CoronavirusDiabetes.org is available in 7 languages.
- Why Is Type 1 Diabetes Misdiagnosed? Many people with Type 1 share a similar diagnosis story. They display all the classic symptoms (extreme thirst, weight loss, frequent urination, nausea) and were fortunate enough to be accurately diagnosed by their primary care doctor. However, some people with Type 1 are not as fortunate to quickly receive a correct diagnosis. This resource explains some of the conditions Type 1 diabetes is often misdiagnosed.
- Check out this award-winning coverage of DKA – Previously Healthy. Shares the backstory of Reegan’s Rule, a Type 1 diabetes screening bill named for a child who passed away after a delayed diagnosis.
- Diabetes highlights two Americas: One where COVID is easily beaten, the other where it’s often devastating: Take a look at this article on how disparities across race and socioeconomic status, often due to systemic racism and implicit bias, continue to impact COVID-19 outcomes. Thank you to Tracey Brown from the American Diabetes Association and Dr. Anne Peters for calling attention to this in this article in USA Today.
- On August 1, Taking Control of Your Diabetes (TCOYD) will be hosting their first-ever entirely virtual conference, geared toward people across the globe living with diabetes, as well as their caretakers and medical professionals. There will also be a HCP component providing CME credits.
- From August 3-6, the first People of Color Living with Diabetes conference is being hosted virtually by Umemba Health, LLC, and Type One Tool. You can sign up for free here.
This site uses Akismet to reduce spam. Learn how your comment data is processed.
Join our mailing list for more about T1D